The Clinical Research of Traditional Chinese Medicine Formula
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorThe Fourth Affiliated Hospital of Zhejiang University School of Medicine
About this trial
This study examines the efficacy and safety of Bushen Huoxue Simiao formula for tonifying the kidneys and promoting blood circulation in treating postoperative complications of upper urinary tract stones, thereby providing evidence-based medical evidence and treatment strategies for clinical practice.
Eligibility criteria
Qualifiers
Meet the Western medicine diagnostic criteria: Patients who need lithotripsy surgery and have a double J stent (4.7F, 28 cm) placed after surgery; plain film of kidney and upper bladder indicates normal position of ureteral stent and no need for stage II surgery.
Meet the Traditional Chinese Medicine (TCM) diagnostic criteria.
Aged between 18 and 80 years old (inclusive).
Voluntary participation with signed informed consent.
Disqualifiers
Patients with renal insufficiency stage 4 or 5, or acute renal failure.
Secondary factors confirmed by examination, such as systemic lupus erythematosus or drug-induced kidney damage.
Does not meet the diagnosis of upper urinary tract stones.
Cases not within the scope of drug action.
Trial design
Treatments tested in this trial
- Bushen Huoxue Simiao Formula
- control group
Treatment groups
80 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov